Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile
The IMID Forum
- Published
- April 14, 2026
- Duration
- 16:32
- Summary source
- description
- Last updated
- Jun 21, 2026
Discusses Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of P…
Summary
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘safety and clinical efficacy of bimekizumab in patients with active PsA who were bDMARD-naïve or TNFi-IR, and the second provided a comprehensive and updated overview of bimekizumab’s safety profile to support c…
Intelligent report
Sign in to read teasers, or upgrade to Research Pro to commission a new dossier for this episode. Learn more →
Show notes
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘safety and clinical efficacy of bimekizumab in patients with active PsA who were bDMARD-naïve or TNFi-IR, and the second provided a comprehensive and updated overview of bimekizumab’s safety profile to support clinical decision-making.